As the 13th IAS Conference on HIV Science (IAS 2025) opens today in Kigali, Rwanda (13–17 July), the global HIV community converges to address pressing challenges and celebrate groundbreaking advancements. This year’s conference, held for the first time in Africa, underscores the continent’s leadership in the HIV response, with Rwanda’s achievement of the **UNAIDS 95-95-95 targets seven years ahead of schedule** serving as a beacon of progress .
Community-Led Advocacy: Bridging Science and Equity
Riako’s advocacy gains further resonance as the World Health Organization (WHO) prepares to launch **new guidelines at IAS 2025, including recommendations for long-acting injectable Lenacapavir for HIV prevention and integrated care for hepatitis/STIs. These updates aim to address gaps in service delivery, particularly for marginalized groups .
Youth at the Forefront: Demanding a Seat at the Table
Plimo’s urgency reflects the conference’s broader theme: sustaining the HIV response amid funding cuts. With global aid disruptions threatening progress, IAS 2025 spotlights African-led innovations, such as AI-driven vaccine research** and differentiated service delivery models, to “do more with less” .
Rwanda’s Dual Challenge: Progress and Persistent Stigma
A Conference of Firsts and Futures
IAS 2025 breaks new ground as the largest HIV science conference in Africa, featuring:
– 1,400+ posters and 100+ sessions, from PrEP innovations to AI in vaccine development.
– Fully funded scholarships* for 500+ attendees from low-income countries, prioritizing underrepresented voices .
– Virtual access to major sessions, ensuring global participation beyond Kigali .